1/2 mek inhibitors for the treatment of peritoneal fibrosis.

摘要

1/2 MEK inhibitors for the treatment of peritoneal fibrosis.; drugs useful in the prevention and treatment of fibrosis of the peritoneal membrane (peritoneal opacification, suntan peritoneum syndrome, mural fibrosis and sclerosing peritonitis syndrome) that occurs as a result of peritoneal dialysis long term method of selecting these drugs and method for collecting data useful in diagnosing the disease.